Renal Failure: Dose Adjustments
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Renal Drug Clearance: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 9, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Matthieu Jamme1, Pierre Galichon, Alexandre Hertig
1Hôpital Tenon, Paris, France.
No abstract available in PubMed .